NCT00910624 Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin (P05514) Status COMPLETED Phase PHASE3
NCT00910000 Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00908544 New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients Status COMPLETED Phase NA
NCT00907738 A Continuation Clinical Trial of Oral Vorinostat (MK-0683) in Advanced Cancers (MK-0683-007) Status COMPLETED Phase PHASE2
NCT00907517 Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247) Status TERMINATED Phase PHASE1
NCT00906087 Effect of Myocilin Genetic Variants on Intraocular Pressure and Pressure Variation in Sitting and Supine Positions Status COMPLETED Phase PHASE4
NCT00903357 The Effectiveness of Montelukast on Atopic Dermatitis in Koreans Status COMPLETED Phase NA
NCT00903006 Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00902161 A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00902070 Protocol for Eslax Intravenous Drug Use Investigation (Study P06082) Status COMPLETED Phase N/A
NCT00896233 Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00895882 Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN) Status WITHDRAWN Phase PHASE2
NCT00895492 Two-year Surveillance of Rotavirus Genotypes Causing Acute Diarrhea in Children Younger Than 5 Years Requiring Emergency Room (ER) and Hospital Admission in Chile Status COMPLETED Phase N/A
NCT00894530 The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638) Status COMPLETED Phase PHASE2
NCT00894114 A Study of Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019) Status COMPLETED Phase PHASE1
NCT00892970 The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period Status COMPLETED Phase PHASE2
NCT00890357 Identifying Factors Underlying the Discontinuation of Triptans Status COMPLETED Phase N/A
NCT00888355 MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension Status COMPLETED Phase PHASE3